Dr. Emmanuel Flahaut obtained his PhD in 1999 from the University of Toulouse. He was a post-doctoral research fellow at Oxford University in the group of Pr Malcolm Green where he worked mainly on the filling of CNT with 1D crystals. He works as a CNRS research director at the CIRIMAT laboratory (Inter-University Centre for Research and Engineering of Materials) at the University of Toulouse, France. His main research fields are the CCVD synthesis, functionalization, dispersion and filling of CNTs (double-walled CNTs in particular), for various applications in the fields of materials science (interconnections in nanoelectronics, composite materials and sensors) and bio-medicine (Gadonanotubes for MRI, CNT scaffolds for tissue engineering, cargoes for drug delivery, etc.) and carbon nanomaterials (CNMs) in general (including graphene, graphene oxide and its reduced forms). He is working on different topics including the human health issues related to CNM, including their synthesis and functionalization, as well as the study of their environmental impact. He is also working on the development of biomedical applications of CNM (currently drug delivery through electroporation of skin and CNM-based antimicrobial surfaces), or applications in sensors, energy storage and nanocomposite materials. He was appointed as a member of the European Academy of Science (EurASc) in 2020.
Dr. Emmanuel Flahaut obtained his PhD in 1999 from the University of Toulouse. He was a post-doctoral research fellow at Oxford University in the group of Pr Malcolm Green where he worked mainly on the filling of CNT with 1D crystals. He works as a CNRS research director at the CIRIMAT laboratory (Inter-University Centre for Research and Engineering of Materials) at the University of Toulouse, France. His main research fields are the CCVD synthesis, functionalization, dispersion and filling of CNTs (double-walled CNTs in particular), for various applications in the fields of materials science (interconnections in nanoelectronics, composite materials and sensors) and bio-medicine (Gadonanotubes for MRI, CNT scaffolds for tissue engineering, cargoes for drug delivery, etc.) and carbon nanomaterials (CNMs) in general (including graphene, graphene oxide and its reduced forms). He is working on different topics including the human health issues related to CNM, including their synthesis and functionalization, as well as the study of their environmental impact. He is also working on the development of biomedical applications of CNM (currently drug delivery through electroporation of skin and CNM-based antimicrobial surfaces), or applications in sensors, energy storage and nanocomposite materials. He was appointed as a member of the European Academy of Science (EurASc) in 2020.